Verinata Bets on Illumina HiSeq 2000 for Non-Invasive Prenatal Aneuploidy Test
October 05, 2011
Verinata Bets on Illumina HiSeq 2000 for Non-Invasive Prenatal Aneuploidy Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Clinical Genome Sequencing Requires Better Standards for Accuracy, Completeness, NHGRI Team Says
August 24, 2011 / Clinical Sequencing News - Illumina and University of Oxford to Sequence 500 Human Genomes to Inform Diagnosis, Treatment
August 3, 2011 / Clinical Sequencing News - Aiming at '$12B Opportunity,' Illumina to Expand Sales Presence, Invest in Reproductive Health
May 14, 2013 / BioArray News - NIPT Developers Consider Sub-Chromosomal Alterations
May 1, 2013 / Clinical Sequencing News - ACMG Cautious of Non-invasive Prenatal Diagnostic Testing in Policy Statement
April 8, 2013 / GenomeWeb Daily News